Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last $ 1.02 ◊ 0.00 (0.00%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Moleculin Biotech Inc | MBRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.03 | -2.86% | 1.02 | 1.06 | 1.01 | 1.06 | 1.05 | 15:59:41 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 1.02 | 1.05 | 0.03 | 2.86% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 542 | 292,713 | $ 1.03 | $ 301,122 | 192,039 | 0.777212 - 2.64 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:23:29 | 99 | $ 1.02 | USD |
Moleculin Biotech Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 46.64M | 45.73M | $ -11.88M | -0.46 | - | 44.28M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Moleculin Biotech News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MBRX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.03 | 1.20 | 1.01 | 1.04 | 332,133 | -0.01 | -0.97% |
| 1 Month | 1.07 | 1.25 | 1.01 | 1.05 | 236,956 | -0.05 | -4.67% |
| 3 Months | 1.18 | 1.30 | 1.01 | 1.09 | 196,929 | -0.16 | -13.56% |
| 6 Months | 1.22 | 1.45 | 0.95 | 1.15 | 237,866 | -0.20 | -16.39% |
| 1 Year | 1.32 | 2.64 | 0.777212 | 1.38 | 808,339 | -0.30 | -22.73% |
| 3 Years | 2.68 | 3.75 | 0.7064 | 1.85 | 816,986 | -1.66 | -61.94% |
| 5 Years | 8.99 | 9.58 | 0.7064 | 1.90 | 709,747 | -7.97 | -88.65% |
Moleculin Biotech Description
| Moleculin Biotech Inc is a clinical-stage pharmaceutical company. The firm focus on the development of oncology drug candidates. The drug technologies used by the company are anthracycline, a portfolio of STAT3 inhibitors, and collection of inhibitors of glycolysis. |
